CAS: 1282512-48-4 - 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
Formula:C24H28N8O2
InChI:InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)
InChI key:InChIKey=BEUQXVWXFDOSAQ-UHFFFAOYSA-N
SMILES:O=C(N)C(N1N=CC(=C1)C2=CC=C3C(OCCN4C=C(N=C34)C5=NC(=NN5C(C)C)C)=C2)(C)C
- Synonyms:
- 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
- GDC 0032
- Taselisib
- RG 7604
- 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetamide
1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
CAS:1282512-48-4
Formula:
C24H28N8O2
Purity:
%
Color and Shape:
Solid
Molecular weight:
460.5315
Ref: IN-DA000XWI
5mg | 64.00 € | ||
10mg | 83.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
9-BROMO-2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPINE
CAS:1282512-48-4
Purity:
95.0%
Molecular weight:
388.2690124511719
Ref: 10-F534332
50mg | 347.00 € | ||
100mg | 554.00 € | ||
250mg | 1,092.00 € | ||
500mg | 1,733.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
Ref: 7W-GW2186
1mg | 218.00 € | ||
5mg | 312.00 € | ||
10mg | 501.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Taselisib
CAS:1282512-48-4
Taselisib (GDC-0032) is an oral PI3K alpha inhibitor with potential cancer-treating properties.
Formula:
C24H28N8O2
Purity:
98.92% - 99.62%
Color and Shape:
Solid
Molecular weight:
460.53
Ref: TM-T1999
2mg | 45.00 € | ||
5mg | 66.00 € | ||
10mg | 90.00 € | ||
25mg | 154.00 € | ||
50mg | 194.00 € | ||
100mg | 343.00 € | ||
200mg | 513.00 € | ||
500mg | 827.00 € | ||
1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
GDC 0032
CAS:1282512-48-4
Inhibitor of PI3K kinase isoforms α, δ, and γ
Formula:
C24H28N8O2
Purity:
Min. 95%
Molecular weight:
460.53 g/mol
Ref: 3D-BG166285
2mg | 136.00 € | ||
5mg | 195.00 € | ||
10mg | 303.00 € | ||
25mg | 452.00 € | ||
50mg | 723.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetamide-d7
Controlled ProductCAS:1282512-48-4
Formula:
C24H21D7N8O2
Color and Shape:
Neat
Molecular weight:
360.361
Ref: TR-D446477
75mg | 17,795.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025